Creative Planning Medi Wound Ltd. Transaction History

Creative Planning

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.86 - $3.24 $23,250 - $40,500	-12,500 Closed	0 $0
Q2 2021 Aug 04, 2021	SELL	$3.38 - $5.71 $16,122 - $27,236	-4,770 Reduced 27.62%	12,500 $48,000
Q1 2021 Apr 30, 2021	BUY	$3.77 - $6.05 $754 - $1,210	200 Added 1.17%	17,270 $93,000
Q4 2020 Jan 29, 2021	SELL	$3.12 - $4.08 $26,520 - $34,680	-8,500 Reduced 33.24%	17,070 $63,000
Q3 2020 Nov 05, 2020	BUY	$3.09 - $4.14 $79,011 - $105,859	25,570 New	25,570 $96,000

Ticker MDWD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,735,200
Market Cap $686M
Description
MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel and bio-therapeutic solutions for tissue repair and regeneration. It markets NexoBrid, a biopharmaceutical product for the removal of eschar, a dead or damaged tissue in adults with deep partial- and full-thickness thermal burns to burn centers and hosp...

Get notified when there are updates to the investment portfolio of Creative Planning, based on Form 13F filings with the SEC.

Stay updated on Creative Planning with notifications on news.